← Leaderboards
Zachary Bennett
Ut Southwestern Medical Center
$107,167
Attributed
$107,167
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $37.9K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$107,167 · 1
By mechanism
F31$107,167 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Angelique Wright Whitehurst$6,833,234
- Nan Yan$13,047,232
- Dian Cao$2,685,861
- Baran D Sumer$4,065,976
- Richard C Wang$4,906,273
Others in their field
Other Emerging Leaders on “Effective Therapy”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$69,114,853
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Yunda Huang · Fred Hutchinson Cancer Center$51,679,442
Research focus
Effective TherapyAgonistAmphiphilicityAdaptor Signaling ProteinAntigen-Presenting CellsAntigensAnti-Tumor Immune ResponseBindingAntigen PresentationAdjuvantCancer VaccinationCancer VaccinesCd86 GeneCellsCell TypeCopolymerCxcl10 GeneCyclic GmpCytokineCytotoxic T-LymphocytesDendritic CellsDoseDraining Lymph NodeEncapsulated
Grant awards (3)
Investigating TLR-agonist adjuvancy in STING-activating nanoparticle cancer vaccines$32,065
F31 · FY2023 · CA · contact PI
Investigating TLR-agonist adjuvancy in STING-activating nanoparticle cancer vaccines$37,909
F31 · FY2022 · CA · contact PI
Investigating TLR-agonist adjuvancy in STING-activating nanoparticle cancer vaccines$37,193
F31 · FY2021 · CA · contact PI